The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 4×
“Furthermore, SOCS proteins appear to inhibit insulin signalling at the level of insulin receptor substrates, although through a different mechanism [145].”
BackgroundInfluentialAdipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“CRP has also been shown to be an independent predictor of both diabetes [97] and CVD [98–100].”
BackgroundInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 1×
“Mice deficient in JNK-1 are resistant to diet-induced JNK activation, IRS-1 serine phosphorylation, and, consequently, insulin resistance, fatty liver and type 2 diabetes [149].”
BackgroundHigh-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162 · cited 1×
“The results of 4 prospective studies, the Framingham Heart Study (FHS), the Lipid Research Clinics Prevalence Mortality Follow-up Study, the Lipid Research Clinics Coronary Primary Prevention Trial (CPPT), and the Multiple Risk Factor Intervention Trial (MRFIT) showed that a 1 mg/dL increase in HDL-C was associated wi…”
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard, J., Maachi, M., Lagathu, C., Kim, M. J., Caron, M., Vidal, H., Capeau, J., & Fève, B. (2006) · PubMed · Cited by 2,496
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,089
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Evidence-Based Eye Care · doi:10.1097/00132578-200307000-00027 · Cited by 1,793
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J.-M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“These, in turn increase serine phosphorylation of IRS-1 leading to inhibition of insulin signalling [153].”
BackgroundRidker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Self-citationManninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Horton, J. D., Shah, N. A., Warrington, J. A., Anderson, N. N., Park, S. W., Brown, M. S., & Goldstein, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534923100 · Cited by 1,270
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226
Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,182
Inflammation and insulin resistance
de Luca, C., & Olefsky, J. M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.057 · Cited by 1,161 · cited 1×
“Visceral obesity has also been defined as an important component of the MetS, and increased visceral fat mass contributes to the development of obesity-related disorders such as insulin resistance, non-alchoholic fatty liver disease, hypertension, diabetes and CVD [127].”
BackgroundInsulin resistance and growth retardation in mice lacking insulin receptor substrate-1
Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994) · Nature · doi:10.1038/372182a0 · Cited by 1,083
Stampfer, M. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110036029 · Cited by 1,079
Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Despre´s, J.-P. (1997) · Circulation · doi:10.1161/01.cir.95.1.69 · Cited by 1,077
Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
SHIMOMURA, I. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00009-5 · Cited by 855
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“The data from the Stanford Five-City Project showed that the incident coronary artery disease cases had significantly smaller LDL peak particle size compared with controls matched for age, sex and ethnicity [170].”
MethodEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 3×
“Insulin resistance in muscle cells reduces glucose uptake, whereas insulin resistance in liver cells results in impaired glycogen synthesis, fails to suppress glucose production, enhances lipogenesis and increases synthesis of proteins such as CRP [3].”
BackgroundInfluentialAdiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Popa, C., Netea, M. G., van Riel, P. L. C. M., van der Meer, J. W. M., & Stalenhoef, A. F. H. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r600021-jlr200 · Cited by 763
MEADE, T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92062-x · Cited by 711
Fröhlich, M., Imhof, A., Berg, G., Hutchinson, W. L., Pepys, M. B., Boeing, H., Muche, R., Brenner, H., & Koenig, W. (2000) · Diabetes Care · doi:10.2337/diacare.23.12.1835 · Cited by 688
Hunt, K. J., Resendez, R. G., Williams, K., Haffner, S. M., & Stern, M. P. (2004) · Circulation · doi:10.1161/01.cir.0000140762.04598.f9 · Cited by 662
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 632
Bastard, J.-P., Maachi, M., van Nhieu, J. T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.-J., Capeau, J., & Hainque, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8450 · Cited by 625
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Alessi, M. C., Peiretti, F., Morange, P., Henry, M., Nalbone, G., & Juhan-Vague, I. (1997) · Diabetes · doi:10.2337/diab.46.5.860 · Cited by 615
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Jialal, I., Devaraj, S., & Venugopal, S. K. (2004) · Hypertension · doi:10.1161/01.hyp.0000130484.20501.df · Cited by 568
Juhan-Vague, I., Pyke, S. D. M., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996) · Circulation · doi:10.1161/01.cir.94.9.2057 · Cited by 552
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis: The Framingham Offspring Study
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P. M., Lipinska, I., D'Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 538
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531 · cited 1×
“Several lines of evidence suggest that insulin resistance plays a central role in development of dyslipidemia, even in non-diabetic insulin resistant subjects [53].”
BackgroundPrevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study
Azizi, F., Salehi, P., Etemadi, A., & Zahedi-Asl, S. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00066-4 · Cited by 526
Goodyear, L. J., Giorgino, F., Sherman, L. A., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 526
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525 · cited 1×
“This dyslipidemia is characterized by increased levels of plasma triglyceride and small, dense low density lipoproteins (sdLDL) and decreased levels of HDL cholesterol [54].”
BackgroundKubota, N., Tobe, K., Terauchi, Y., Eto, K., Yamauchi, T., Suzuki, R., Tsubamoto, Y., Komeda, K., Nakano, R., Miki, H., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1880 · Cited by 521
THE INSULIN RESISTANCE SYNDROME: Definition and Dietary Approaches to Treatment
Reaven, G. M. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132155 · Cited by 516 · cited 1×
“The term MetS, also referred to as the insulin resistance syndrome or syndrome X refers to a cluster of correlated disorders that include glucose intolerance, insulin resistance, obesity, dyslipidemia, and hypertension [4].”
BackgroundHow hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 504
Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
The SOCS box: a tale of destruction and degradation
Kile, B. T., Schulman, B. A., Alexander, W. S., Nicola, N. A., Martin, H. M. E., & Hilton, D. J. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02085-6 · Cited by 431
Danaei, G., Lawes, C. M., Vander Hoorn, S., Murray, C. J., & Ezzati, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69700-6 · Cited by 414
Small LDL, Atherogenic Dyslipidemia, and the Metabolic Syndrome
Grundy, S. M. (1997) · Circulation · doi:10.1161/01.cir.95.1.1 · Cited by 402
PAI-1 and the Metabolic Syndrome: Links, Causes, and Consequences
Alessi, M.-C., & Juhan-Vague, I. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000242905.41404.68 · Cited by 390
The lipid phosphatase SHIP2 controls insulin sensitivity
Clément, S., Krause, U., Desmedt, F., Tanti, J.-F., Behrends, J., Pesesse, X., Sasaki, T., Penninger, J., Doherty, M., Malaisse, W., et al. (2001) · Nature · doi:10.1038/35051094 · Cited by 376
Metabolic syndrome and cardiovascular disease
Qiao, Q., Gao, W., Zhang, L., Nyamdorj, R., & Tuomilehto, J. (2007) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1258/000456307780480963 · Cited by 376
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Insulin resistance in hepatocytes and sinusoidal liver cells: Mechanisms and consequences
Leclercq, I. A., Da Silva Morais, A., Schroyen, B., Van Hul, N., & Geerts, A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.002 · Cited by 359
Björnholm, M., Kawano, Y., Lehtihet, M., & Zierath, J. R. (1997) · Diabetes · doi:10.2337/diab.46.3.524 · Cited by 359
Mechanisms of Hepatic Very Low Density Lipoprotein Overproduction in Insulin Resistance
Taghibiglou, C., Carpentier, A., Van Iderstine, S. C., Chen, B., Rudy, D., Aiton, A., Lewis, G. F., & Adeli, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8416 · Cited by 347
Self-citationRelationship between degree of obesity and in vivo insulin action in man
Bogardus, C., Lillioja, S., Mott, D. M., Hollenbeck, C., & Reaven, G. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.3.e286 · Cited by 344
Bonora, E., Kiechl, S., Willeit, J., Oberhollenzer, F., Egger, G., Meigs, J. B., Bonadonna, R. C., & Muggeo, M. (2007) · Diabetes Care · doi:10.2337/dc06-0919 · Cited by 343
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 1×
“Animals with liver specific deletion of the insulin receptor show severe glucose intolerance [49] whereas normal glucose and insulin levels were found in mice with a deletion of the insulin receptor in skeletal muscle and adipose [50,51], suggesting that hepatic insulin resistance is necessary to develop hyperglycemia…”
BackgroundOLOFSSON, S. ‐., & BORÈN, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01556.x · Cited by 330
Shahar, E., Chambless, L. E., Rosamond, W. D., Boland, L. L., Ballantyne, C. M., McGovern, P. G., & Sharrett, A. R. (2003) · Stroke · doi:10.1161/01.str.0000057812.51734.ff · Cited by 325 · cited 1×
“More recent epidemiological studies including the British cohort [173], the Honolulu heart program [174], and the Atherosclerosis Risk in Communities (ARIC) study [175] have demonstrated a significant inverse association between serum HDL-C and ischemic stroke risk.”
BackgroundInsulin resistance in type 2 diabetes: role of fatty acids
Arner, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.254 · Cited by 323
Molecular mechanisms of insulin resistance
Schinner, S., Scherbaum, W. A., Bornstein, S. R., & Barthel, A. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01566.x · Cited by 319
Interleukin-6 stimulates hepatic triglyceride secretion in rats
Nonogaki, K. (1995) · Endocrinology · doi:10.1210/en.136.5.2143 · Cited by 304
Samad, F., Yamamoto, K., & Loskutoff, D. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118404 · Cited by 301
Alexander, C. M., Landsman, P. B., & Teutsch, S. M. (2003) · Cited by 292
Ahmad, F., Azevedo, J. L., Cortright, R., Dohm, G. L., & Goldstein, B. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119552 · Cited by 289
Alessi, M. C., Juhan-Vague, I., Kooistra, T., Declerck, P. J., & Collen, D. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646997 · Cited by 289
Hall, R. K., Yamasaki, T., Kucera, T., Waltner-Law, M., O'Brien, R., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004898200 · Cited by 284
Pirola, L., Johnston, A. M., & Van Obberghen, E. (2004) · Diabetologia · doi:10.1007/s00125-003-1313-3 · Cited by 283
Suppressors of Cytokine Signaling-1 and -6 Associate with and Inhibit the Insulin Receptor
Mooney, R. A., Senn, J., Cameron, S., Inamdar, N., Boivin, L. M., Shang, Y., & Furlanetto, R. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010579200 · Cited by 282
Borggreve, S. E., De Vries, R., & Dullaart, R. P. F. (2003) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2003.01263.x · Cited by 278
Rashid, S., Watanabe, T., Sakaue, T., & Lewis, G. F. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00078-x · Cited by 277
Smith, A., Patterson, C., Yarnell, J., Rumley, A., Ben-Shlomo, Y., & Lowe, G. (2005) · Circulation · doi:10.1161/circulationaha.105.557132 · Cited by 256
On the Control of Lipolysis in Adipocytes
LONDOS, C., BRASAEMLE, D. L., SCHULTZ, C. J., ADLER‐WAILES, D. C., LEVIN, D. M., KIMMEL, A. R., & RONDINONE, C. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07794.x · Cited by 251
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s39-s46 · Cited by 249
De novo lipogenesis in humans: metabolic and regulatory aspects
Hellerstein, M. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600744 · Cited by 246
Prada, P. O., Zecchin, H. G., Gasparetti, A. L., Torsoni, M. A., Ueno, M., Hirata, A. E., Corezola do Amaral, M. E., Höer, N. F., Boschero, A. C., & Saad, M. J. A. (2005) · Endocrinology · doi:10.1210/en.2004-0767 · Cited by 244
Taghibiglou, C., Rashid-Kolvear, F., Van Iderstine, S. C., Le-Tien, H., Fantus, I. G., Lewis, G. F., & Adeli, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106737200 · Cited by 236
Self-citationLipoprotein lipase and the disposition of dietary fatty acids
Fielding, B. A., & Frayn, K. N. (1998) · British Journal of Nutrition · doi:10.1017/s0007114598001585 · Cited by 231
Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein
Packard, C. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311066 · Cited by 225
Folsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V. L., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 225
Kroder, G., Bossenmaier, B., Kellerer, M., Capp, E., Stoyanov, B., Mühlhöfer, A., Berti, L., Horikoshi, H., Ullrich, A., & Häring, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118569 · Cited by 222
HDL-Cholesterol, Total Cholesterol, and the Risk of Stroke in Middle-Aged British Men
Wannamethee, S. G., Shaper, A. G., & Ebrahim, S. (2000) · Stroke · doi:10.1161/01.str.31.8.1882 · Cited by 220 · cited 1×
“More recent epidemiological studies including the British cohort [173], the Honolulu heart program [174], and the Atherosclerosis Risk in Communities (ARIC) study [175] have demonstrated a significant inverse association between serum HDL-C and ischemic stroke risk.”
BackgroundSpecific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic Mice
Butler, M., McKay, R. A., Popoff, I. J., Gaarde, W. A., Witchell, D., Murray, S. F., Dean, N. M., Bhanot, S., & Monia, B. P. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1028 · Cited by 216
Kissebah, A. H., Alfarsi, S., Adams, P. W., & Wynn, V. (1976) · Diabetologia · doi:10.1007/bf01220632 · Cited by 199
Lin, M. C., Gordon, D., & Wetterau, J. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39865-5 · Cited by 198
Metabolic Syndrome and the Risk of Cardiovascular Disease in Older Adults
Butler, J., Rodondi, N., Zhu, Y., Figaro, K., Fazio, S., Vaughan, D. E., Satterfield, S., Newman, A. B., Goodpaster, B., Bauer, D. C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.046 · Cited by 194
Hypercoagulability in the metabolic syndrome
Nieuwdorp, M., Stroes, E. S., Meijers, J. C., & Büller, H. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.003 · Cited by 190
Studies on the assembly of apo B-100-containing lipoproteins in HepG2 cells.
Boström, K., Borén, J., Wettesten, M., Sjöberg, A., Bondjers, G., Wiklund, O., Carlsson, P., & Olofsson, S. O. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68945-8 · Cited by 189
Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line
Kaszubska, W., Falls, H. D., Schaefer, V. G., Haasch, D., Frost, L., Hessler, P., Kroeger, P. E., White, D. W., Jirousek, M. R., & Trevillyan, J. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00178-8 · Cited by 189
Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice
Samad, F., & Loskutoff, D. J. (1996) · Molecular Medicine · doi:10.1007/bf03401641 · Cited by 188
Insulin Receptor Substrate 3 Is Not Essential for Growth or Glucose Homeostasis
Liu, S. C. H., Wang, Q., Lienhard, G. E., & Keller, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.18093 · Cited by 188
Atherogenic dyslipidemia and the metabolic syndrome.
Soegondo, S. (2005) · PubMed · Cited by 188
Kruszynska, Y. T., Yu, J. G., Olefsky, J. M., & Sobel, B. E. (2000) · Diabetes · doi:10.2337/diabetes.49.4.633 · Cited by 185
Fatty acids and insulin resistance in muscle and liver
Kovacs, P. L., & Stümvoll, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.003 · Cited by 182
U.K. Prospective Diabetes Study Group (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1683 · Cited by 179
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
Utzschneider, K. M., Carr, D. B., Tong, J., Wallace, T. M., Hull, R. L., Zraika, S., Xiao, Q., Mistry, J. S., Retzlaff, B. M., Knopp, R. H., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1932-y · Cited by 174
Wolfrum, C., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.001 · Cited by 166
C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes.
Kuta, A. E., & Baum, L. L. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.1.321 · Cited by 161
New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
Vergès, B. L. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70213-6 · Cited by 160
Gervois, P. P., Vu‐Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J., Kooistra, T., & Staels, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102839200 · Cited by 160
The connection between C‐reactive protein and atherosclerosis
Singh, S. K., Suresh, M. V., Voleti, B., & Agrawal, A. C. (2008) · Annals of Medicine · doi:10.1080/07853890701749225 · Cited by 158
Collet, J. P., Montalescot, G., Vicaut, E., Ankri, A., Walylo, F., Lesty, C., Choussat, R., Beygui, F., Borentain, M., Vignolles, N., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083471.33820.3c · Cited by 158
Pathophysiology and biochemistry of cardiovascular disease
Scott, J. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.04.012 · Cited by 153
Hadigan, C. M., Meigs, J. B., Rabe, J., D’Agostino, R. B., Wilson, P. W. F., Lipinska, I., Tofler, G. H., & Grinspoon, S. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7410 · Cited by 147
Liao, J., Barthel, A., Nakatani, K., & Roth, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27320 · Cited by 141
Wajngot, A., Chandramouli, V., Schumann, W. C., Ekberg, K., Jones, P. K., Efendic, S., & Landau, B. R. (2001) · Metabolism · doi:10.1053/meta.2001.19422 · Cited by 138
Riemens, S. C., van Tol, A., Sluiter, W. J., & Dullaart, R. P. F. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00111-7 · Cited by 133
Haj, F. G., Zabolotny, J. M., Kim, Y., Kahn, B. B., & Neel, B. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413240200 · Cited by 132
Signalling mechanisms linking hepatic glucose and lipid metabolism
Weickert, M. O., & Pfeiffer, A. F. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0295-3 · Cited by 127 · cited 1×
“Various kinases including stress activated protein kinase, c-Jun N-terminal kinase (JNK), and PKC can phosphorylate IRS-1,2 at specific serine and threonine residues, leading to inhibition of insulin signalling [35].”
BackgroundMavri, A., Alessi, M., Georgelin, O., Fina, F., Sentočnik, J. T., Bastelica, D., Stegnar, M., & Juhan-Vague, I. (2001) · Diabetologia · doi:10.1007/s001250100007 · Cited by 122
Phung, T. L., Roncone, A. M., Jensen, K. L. D. M., Sparks, C. E., & Sparks, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30693 · Cited by 122
Fatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg, J., Strömblad, G., Wirth, A. G., Smith, U., & Björntorp, P. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115534 · Cited by 121
The UK Prospective Diabetes study
Turner, R. C., Holman, R. R., & Saration, I. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60426-6 · Cited by 108
High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria
Ko, G. T.-C., Cockram, C. S., Chow, C., Yeung, M. W., Chan, W. B., So, W., Chan, N. N., & Chan, J. C. N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.015 · Cited by 108
Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus
Bagdade, J. D., Lane, J. D., Subbaiah, P. V., OTTO, M., & Ritter, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90177-v · Cited by 106
Insulin Responsiveness of Adipose Tissue Lipoprotein Lipase Is Delayed but Preserved in Obesity*
SADUR, U. N., Yost, T. J., & Eckel, R. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1176 · Cited by 106
Nontraditional cardiovascular risk factors in pediatric metabolic syndrome
Retnakaran, R. R., Zinman, B., Connelly, P. W., Harris, S. B., & Hanley, A. J. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.08.025 · Cited by 103
Halle, M., Berg, A., Northoff, H., & Keul, J. (1998) · PubMed · Cited by 100
Rega‐Kaun, G., Kaun, C., Weiss, T. W., Demyanets, S., Zorn, G., Kastl, S., Steiner, S., Seidinger, D., Kopp, C. W., Frey, M., et al. (2005) · Circulation · doi:10.1161/01.cir.0000161823.55935.be · Cited by 97
Voleti, B., & Agrawal, A. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3386 · Cited by 94
Lessons from UK prospective diabetes study
Turner, R. C., & Holman, R. R. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01105-m · Cited by 94
Sparks, J. D., Phung, T. L., Bolognino, M., & Sparks, C. E. (1996) · Biochemical Journal · doi:10.1042/bj3130567 · Cited by 94
Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Chen, R., Popper, J. S., Petrovitch, H., Ross, G. W., Schatz, I. J., Belleau, G. C., et al. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh177 · Cited by 93
Siri, P. W., Candela, N. M., Zhang, Y., Ko, C., Eusufzai, S., Ginsberg, H. N., & Huang, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108909200 · Cited by 79
Transcriptional Regulation of Plasminogen Activator Inhibitor Type 1 Gene by Insulin
Banfi, C., Eriksson, P. O., Giandomenico, G., Mussoni, L., Sironi, L., Hamsten, A., & Tremoli, E. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1522 · Cited by 75
Adeli, K. (2003) · Frontiers in bioscience · doi:10.2741/1022 · Cited by 72
Self-citationApolipoprotein B Is Intracellularly Associated with an ER-60 Protease Homologue in HepG2 Cells
Adeli, K., Macri, J., Mohammadi, A., Kito, M., Urade, R., & Cavallo, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22489 · Cited by 63
Self-citationYang, R., Wilcox, D. M., Haasch, D. L., Jung, P. M., Nguyen, P., Voorbach, M. J., Doktor, S. Z., Brodjian, S. J., Bush, E. N., Lin, E. P.-Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700790200 · Cited by 62
Relationships between fibrinogen and insulin resistance
de Mauverger, É. R., Pérez‐Martin, A., Brun, J. ‐., Aïssa-Benhaddad, A., Fédou, C., & Mercier, J. G. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00373-1 · Cited by 62
Banfi, C., Mussoni, L., Risé, P., Cattaneo, M. G., Vicentini, L. M., Battaini, F., Galli, C., & Tremoli, E. (1999) · Circulation Research · doi:10.1161/01.res.85.2.208 · Cited by 60
Reaven, G. M., & Mondon, C. (1984) · Hormone and Metabolic Research · doi:10.1055/s-2007-1014753 · Cited by 59
Relation of the size and intracellular sorting of apoB to the formation of VLDL 1 and VLDL 2
Stillemark-Billton, P., Adiels, C. B., Borén, J., & Olofsson, S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400296-jlr200 · Cited by 56
Adeli, K., & Theriault, A. (1992) · Biochemistry and Cell Biology · doi:10.1139/o92-177 · Cited by 55
Self-citationMeshkani, R., Taghikhani, M., Al‐Kateb, H., Larijani, B. A., Khatami, S., Sidiropoulos, K. G., Hegele, R. A., & Adeli, K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.088146 · Cited by 51
Self-citationJeppesen, J., Hansen, T. W., Rasmussen, S. L., Ibsen, H., & Torp-Pedersen, C. T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.010 · Cited by 50
Resistin and Adiponectin—of Mice and Men
Stümvoll, M., & Häring, H. U. (2002) · Obesity Research · doi:10.1038/oby.2002.162 · Cited by 46
Young, D. P., Kushner, I., & Samols, D. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2420 · Cited by 45
Prevalence of the Metabolic Syndrome Among Adult New Zealanders of Polynesian and European Descent
Simmons, D. S., & Thompson, C. F. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.3002 · Cited by 42
Au, C., Wagner, A., Chong, T. M., Qiu, W., Sparks, J. D., & Adeli, K. (2004) · Metabolism · doi:10.1016/j.metabol.2003.09.011 · Cited by 40
Self-citationMeshkani, R., Taghikhani, M., Larijani, B. A., Khatami, S., Khoshbin, E., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.03.018 · Cited by 37
Self-citationMeshkani, R., Taghikhani, M., Mosapour, A., Larijani, B. A., Khatami, S., Khoshbin, E., Ahmadvand, D., Saidi, P., Maleki, A. R., Yavari, K., et al. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.01.010 · Cited by 27
Self-citationHepatic glucose production: therapeutic target in type 2 diabetes?
Stæhr, P., Nielsen, O. H., & Beck‐Nielsen, H. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00177.x · Cited by 26
Nagi, D. K., Tracy, R. P., & Pratley, R. E. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90242-5 · Cited by 26
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Similar to the case in insulin-sensitive tissues, in states of IR, physiologic levels of circulating insulin are insufficient to elicit the appropriate insulin response in hepatic cells [176].”
BackgroundAnti-inflammatory activity of natural dietary flavonoids
Pan, M.-H., Lai, C.-S., & Ho, C.-T. (2010) · Food & Function · doi:10.1039/c0fo00103a · Cited by 605
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031094 · Cited by 328
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani-Firuzjaee, S., Panahi, G., & Meshkani, R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.08.011 · Cited by 295
Self-citationRegulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274
“This, in part, is mediated by actions in the liver, which can regulate systemic responses to insulin [288].”
Background
Metadata
- Authors
- Meshkani, R., & Adeli, K.
- Venue
- Clinical Biochemistry
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 42
- Issue
- 13-14
- Pages
- 1331-1346
- ISSN
- 0009-9120 (ISSN-L)
- OpenAlex
- W2040732264
- Cited by
- 458
- References
- 186
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.